Reinvigorating Antibiotic and Diagnostic Innovation Act of 2015
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Sep 17, 2015)
Reinvigorating Antibiotic and Diagnostic Innovation Act of 2015
This bill amends the Internal Revenue Code to allow tax credits for 50% of the clinical testing expenses for: (1) infectious disease products that are intended to treat a serious or life-threatening infection, including one caused by an antibacterial or antifungal resistant pathogen or a qualifying pathogen listed by the Department of Health and Human Services as having the potential to pose a serious threat to public health; and (2) in-vitro diagnostic devices that identify in less than four hours the presence, concentration, or characteristics of a serious or life-threatening infection.
What just happenedSep 17, 2015
Referred to the House Committee on Ways and Means.
Who’s behind it
- Introduced in HouseSep 17, 2015
- Sep 17, 2015IntroReferralH11100
Referred to the House Committee on Ways and Means.
Ways and Means Committee - Sep 17, 2015IntroReferralIntro-H
Introduced in House
- Sep 17, 2015IntroReferral1000
Introduced in House